Benzoxaborole antimalarial agents. Part 4. Discovery of potent 6-(2-(alkoxycarbonyl)pyrazinyl-5-oxy)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles.
Benzoxaborole antimalarial agents. Part 4. Discovery of potent 6-(2-(alkoxycarbonyl)pyrazinyl-5-oxy)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles.
复制标题
苯唑替洛尔抗疟药。第4部分。发现有效的6-(2-(2-(AlkoxyCarbonyl)吡唑)-5-oxy)-1,3-二氢-1-羟基-2,1-苯并oxoxaboroles。
DOI:
10.1021/acs.jmedchem.5b00678
复制
发表时间:
2015-07-09
影响因子:
7.3
通讯作者:
Yang Y
中科院分区:
文献类型:
--
作者:
Zhang YK;Plattner JJ;Easom EE;Jacobs RT;Guo D;Sanders V;Freund YR;Campo B;Rosenthal PJ;Bu W;Gamo FJ;Sanz LM;Ge M;Li L;Ding J;Yang Y
A series of 6-hetaryloxy benzoxaborole compounds was designed and synthesized for a structure–activity relationship (SAR) investigation to assess the changes in antimalarial activity which result from 6-aryloxy structural variation, substituent modification on the pyrazine ring, and optimization of the side chain ester group. This SAR study discovered highly potent 6-(2-(alkoxycarbonyl)pyrazinyl-5-oxy)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles (9, 27–34) with IC50s = 0.2–22 nM against cultured Plasmodium falciparum W2 and 3D7 strains. Compound 9 also demonstrated excellent in vivo efficacy against P. berghei in infected mice (ED90 = 7.0 mg/kg).